Neurosense Therapeutics Stock Forecast

Hold candidate since Jun 05, 2026

The NeuroSense Therapeutics Ltd. stock price fell by -3.85% on the last day (Friday, 5th Jun 2026) from $0.780 to $0.750. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 13.70% from a day low at $0.730 to a day high of $0.83. The price has fallen in 7 of the last 10 days and is down by -2.96% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -164 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.709 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.14% during the next 3 months and, with a 90% probability hold a price between $0.739 and $1.00 at the end of this 3-month period.

NRSN Signals & Forecast

There are few to no technical positive signals at the moment. The NeuroSense Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.80 and $0.81. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -16.22%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for NeuroSense Therapeutics Ltd. stock

NeuroSense Therapeutics Ltd. finds support from accumulated volume at $0.731 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.1000 between high and low, or 13.70%. For the last week the stock has had daily average volatility of 8.63%

Our recommended stop-loss: $0.704 (-6.18%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (NRSN) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect NeuroSense Therapeutics Ltd. to open at $0.770, and during the day (based on 14 day Average True Range), to move between $0.717 and $0.783, which gives a possible trading interval of +/-$0.0665 (+/-9.28%) up or down from last closing price. If NeuroSense Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 9.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.762 (1.59%) than the support at $0.731 (2.55%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NeuroSense Therapeutics Ltd. stock A Buy?

NeuroSense Therapeutics Ltd. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.636 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.770 ( 2.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk